NSEPress Release (Revised)▲ PositiveExpansion31 Jul 2026
Aether Industries Limited
Press Release (Revised)
Aether Industries Limited, a specialty chemical manufacturer, has collaborated with Dow Chemical International Private Limited to launch a research program to develop new manufacturing technologies for silicones.
BSECompany Update▲ PositiveExpansion31 Jul 2026
Aether Industries Ltd
Revised Press Release.
Aether Industries Ltd has collaborated with Dow Chemical International Pvt. Ltd. to develop new manufacturing technologies for silicones. The program will be executed at Aether's R&D and pilot facilities in Surat, Gujarat. This collaboration represents a milestone in advancing domestic innovation and has the potential for long-term commercialization and industrial-scale manufacture of technologies developed through the program.
BSECompany Update▲ PositiveResults31 Jul 2026
Strides Pharma Science Ltd
Earnings Presentation for the quarter ended June 30, 2026
Strides Pharma Science Ltd has announced its Q1FY27 earnings, with revenue growth of 13% YoY, and EBITDA growth of 5.4% YoY, despite a ₹131m impact on freight and operating costs from geopolitical disruptions. The company has also unlocked ₹1,000m of value through the divestment of its majority stake in Pivot Path, and improved its EcoVadis sustainability score to 68/100, a 19-point increase over last year.
BSECompany Update▲ PositiveResults31 Jul 2026
Onesource Specialty Pharma Ltd
Intimation of Transcript of Earnings call dated July 25, 2026
OneSource Specialty Pharma Ltd has announced its Q1 FY27 earnings, with revenues at INR4,490 million, a 37% year-on-year growth, driven by the semaglutide commercial launch, new MSA contracts, and new customer wins. EBITDA has also grown 39% year-on-year and 34% sequentially.
BSECompany Update▲ PositiveResults31 Jul 2026
Strides Pharma Science Ltd
Strides Delivers Steady Performance with Q1FY27; Revenue at Rs. 12,654m, Grew 13% YoY; Ex-US Markets Grew 17% YoY
Strides Pharma Science Ltd reported Q1FY27 results with revenue at ₹12,654m, a 13% YoY growth, driven by 17% YoY growth in Ex-US Markets. EBITDA grew 5.4% YoY to ₹2,298m, despite a ₹131m impact on operating costs from geopolitical disruptions. The company unlocked ₹1,000m of value through the divestment of its majority stake in Pivot Path, its captive GCC, while retaining meaningful participation in its future growth.
NSEGeneral Updates▲ PositiveResults31 Jul 2026
Strides Pharma Science Limited
General Updates
Strides Pharma Science Limited has announced its Q1 FY 2027 earnings, with revenue growing 13% YoY to ₹12,654m, and EBITDA growing 5.4% YoY to ₹2,298m. The company has also divested its majority stake in Pivot Path, a captive GCC, and unlocked ₹1,000m of value. The company has improved its EcoVadis sustainability score to 68/100, a 19-point increase over last year.
NSEPress Release▲ PositiveResults31 Jul 2026
Shadowfax Technologies Limited
Press Release
Shadowfax Technologies Limited has announced its Q1 FY27 financial results, with revenue growing 64.9% YoY to ₹1,358 Cr, Adjusted EBITDA margin expanding to 4.9%, and PAT reaching an all-time high of ₹65 Cr.
NSEPress Release▲ PositiveResults31 Jul 2026
Strides Pharma Science Limited
Press Release
Strides Pharma Science Limited has announced its consolidated financial results for the quarter (Q1FY27) ended 30 June, 2026, with revenue at ₹12,654m, growing 13% YoY, and EBITDA at ₹2,298m, growing 5.4% YoY.
BSECompany Update▲ PositiveResults31 Jul 2026
Shadowfax Technologies Ltd
Press Release on the Financial Results for the Quarter Ended June 30, 2026
Shadowfax Technologies Ltd reported its Q1 FY27 performance, achieving record revenue, margins, and profitability. Revenue grew 64.9% YoY to ₹1,358 Cr, Adjusted EBITDA margin expanded to 4.9%, and PAT reached an all-time high of ₹65 Cr.
NSEOutcome of Board Meeting▲ PositiveResults31 Jul 2026
Strides Pharma Science Limited
Outcome of Board Meeting
Strides Pharma Science Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, to the National Stock Exchange of India and the Bombay Stock Exchange. The results were approved by the Board of Directors at their meeting held on July 31, 2026. The financial results are available on the company's website at www.strides.com.
NSEOutcome of Board Meeting▲ PositiveResults31 Jul 2026
Hybrid Financial Services Limited
Outcome of Board Meeting
Hybrid Financial Services Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, showing a total income of Rs. 151.43 crores and a profit before tax of Rs. 58.22 crores. The company's principal business is stock broking and allied activities.
NSEPress Release▲ PositiveOrder Win31 Jul 2026
Aether Industries Limited
Press Release
Aether Industries Limited, a specialty chemical manufacturer, has collaborated with Dow Chemical International Private Limited on a research program to develop new manufacturing technologies for silicones in India.
NSEGeneral Updates▲ PositiveExpansion31 Jul 2026
Alicon Castalloy Limited
General Updates
Alicon Castalloy Limited has informed the Exchange about setting-up of a new manufacturing facilities/plant for GDC, LPDC, and Machining with a capital outlay of Rs.1,255 million.
NSEInvestor Presentation▲ PositiveResults31 Jul 2026
Aether Industries Limited
Investor Presentation
Aether Industries Limited has informed the Exchange about Investor Presentation, with Frequently Asked Questions (FAQs) on the presentation shared, including quarterly performance, site nomenclature, operations and supply chain, and capital expenditure.
BSECompany Update▲ PositiveResults31 Jul 2026
Aether Industries Ltd
In accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we further share the FAQs to the investor presentation, as annexed.
Aether Industries Ltd reported strong quarterly sales growth of 27% YoY and 7% QoQ, driven by 75% YoY growth in Contract and Exclusive Manufacturing (CEM) and 20% YoY growth in Contract Research and Manufacturing Services (CRAMS). The company also provided an update on its manufacturing sites, with new names and a focus on diversification across sectors.
NSEInvestor Presentation▲ PositiveResults31 Jul 2026
Aether Industries Limited
Investor Presentation
Aether Industries Limited has announced its Q1 FY27 financial results, showing a 27% YoY growth in operating revenue to ₹3,051 M, with a 31% YoY growth in EBITDA to ₹814 M and a 33% YoY growth in PAT to ₹540 M. The company has also provided an update on its R&D expansion plans, including the installation of 18 fume hoods and the construction of a new R&D building.
BSECompany Update▲ PositiveResults31 Jul 2026
Aether Industries Ltd
In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the investor presentation is annexed herewith.
Aether Industries Ltd has announced its Q1 FY27 financial results, with a 27% YoY growth in operating revenue to ₹3,051 M, driven by growing CEM contracts and price-led LSM demand. The company has also reported a 31% YoY growth in EBITDA to ₹814 M, and a 33% YoY growth in profit after tax to ₹540 M.
BSECompany Update▲ PositiveExpansion31 Jul 2026
Alicon Castalloy Ltd
Intimation about setting-up a new manufacturing facilities/plant.
Alicon Castalloy Ltd has announced the setting up of a new manufacturing facility for GDC, LPDC, and machining with a capital outlay of Rs. 1,255 million, to be financed by borrowing and internal accruals.
BSECompany Update▲ PositiveOrder Win31 Jul 2026
Vikran Engineering Ltd
Press Release -Vikran Engineering Secures Rs. 120.69 Crore order from POWERGRID for 400 kV GIS Substation Extension Package SS-147
Vikran Engineering Ltd has secured a ₹120.69 Crore order from Power Grid Corporation of India Ltd for the 400 kV GIS Substation Extension Package SS-147.
BSECompany Update▲ PositiveExpansion31 Jul 2026
Bajaj Finserv Ltd
The Board has granted approval for pursuing re-insurance business through a subsidiary of the Company to be incorporated, subject to approval of IRDAI and other authorities, as may be necessary.
Bajaj Finserv Ltd's board has approved pursuing re-insurance business through a subsidiary, subject to IRDAI and other authorities' approval.